# Combination Therapy Using Cellcept and Rebif in RRMS

> **NCT00618527** · EARLY_PHASE1 · COMPLETED · sponsor: **Aaron Boster** · enrollment: 31 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** mycophenolate mofetil (Cellcept)
- **DRUG:** human interferon beta 1a (Rebif)

## Key facts

- **NCT ID:** NCT00618527
- **Lead sponsor:** Aaron Boster
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2012-11-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00618527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00618527, "Combination Therapy Using Cellcept and Rebif in RRMS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00618527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*